Rhonda Robb brings more than 25 years of experience to the New Brighton-based cardiovascular device maker.

The National Business Group on Health says employers are looking beyond benefits designed for more health care bang for their buck.

A Phase I study has opened for non-Hodgkin lymphoma and multiple myeloma patients.

Bad-debt expenses also increased at hospitals in the state, a report from the Minnesota Hospital Association found.

Publicly-traded Harvard Bioscience Inc. is the buyer.

Neurodegenerative and liver disease are among the targets of Regenerative Medicine Minnesota.

The Rochester-based health care provider and Veritas Genetics are launching an effort aimed at greatly extending WGS availability.

The Centers for Disease Control and Prevention said health care employers need to do more to protect employees, patients and visitors.

The insurer expects its earnings and cash flow will jump by $1.7 billion in 2018 as a result of the recently-passed federal tax reform.

A spokesperson said that Medtronic didn’t yet know the total number of employees that would be impacted by their new restructuring plan, but that the company is still on track to make good on their pledge to create 1,000 jobs in the state since moving their HQ to Ireland in 2015.

Each physician in the state was responsible for an average of $2.3 million in economic activity.

A preclinical study between Mayo and collaborator Corindus Vascular Robotics will test a remote-controlled ‘telestenting’ system in face of likely cardiologist shortfall.

The foundation said it would also donate the same amount and more to 37 organizations, many of which are from Minnesota.

Overall, the company expects to save the $3 billion by the end of its 2022 fiscal year.

Zyga’s flagship product is used to treat chronic pain within the lower spine.